Masters of Longevity - The Pulse

  1. THE LIVE Barcelona 2026 (Barcelona, Spain)26. OCT 2026 - 28. OCT 2026THE LIVE Barcelona 2026Media PartnerSummit - Barcelona, Spain★
  2. CEE Longevity Summit & Retreat 2026 (Samorin, Slovakia)29. OCT 2026 - 31. OCT 2026CEE Longevity Summit & Retreat 2026Retreat - Samorin, Slovakia
  3. Parkhotel Longevity Retreat — October 2026 (Bad Bayersoien, Germany)31. OCT 2026 - 8. NOV 2026Parkhotel Longevity Retreat — October 2026Retreat - Bad Bayersoien, Germany
  4. Biology of Aging Symposium V 2026: The Possibilities of Aging and Health (Montreal, Canada)1. NOV 2026 - 3. NOV 2026Biology of Aging Symposium V 2026: The Possibilities of Aging and HealthConference - Montreal, Canada
  5. Atlas Cove Longevity Residency — November 2026 (Setúbal, Portugal)1. NOV 2026 - 6. NOV 2026Atlas Cove Longevity Residency — November 2026Retreat - Setúbal, Portugal
Science Daily - Health & Medicine25 Oct 2026
Mediterranean diet may boost tiny proteins that protect the heart and brain (Science Daily - Health & Medicine)

Mediterranean diet may boost tiny proteins that protect the heart and brain

An observational study linked dietary patterns to blood markers in older adults. It cannot establish cause and effect.

Key takeaways
  • The observational study cannot show that diet caused these differences.
  • Older adults with higher Mediterranean adherence had higher Humanin levels.
  • Greater Mediterranean adherence was associated with higher SHMOOSE levels.
PR Newswire25 Oct 2026
The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The N

The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine

Sac-TMT plus pembrolizumab delayed progression in selected advanced lung cancer patients. Overall survival remains preliminary.

Key takeaways
  • The trial enrolled PD-L1-negative patients without EGFR or ALK mutations.
  • Median progression-free survival was 15.0 months versus 5.7 months.
  • An overall survival benefit has not yet been established.
Nature - Biotechnology25 Oct 2026
AIHolographic focused ultrasound enables multitarget EV and MSC delivery for neurovascular repair after ischemic stroke (Nature - Biotechnology)

Holographic focused ultrasound enables multitarget EV and MSC delivery for neurovascular repair after ischemic stroke

In male mice after transient focal ischemia, a two‑minute HaMBO session opened the BBB and improved recovery.

Key takeaways
  • HaMBO was a holographic ultrasound system using 3D‑printed holograms.
  • A single two‑minute HaMBO session increased EV and MSC peri‑infarct delivery.
  • Findings were in male mice; human efficacy and safety remain unproven.